Senior Director Program Management @ (December 2022 - August 2024)
Project Management Consultant @ (June 2020 - December 2022)
Independent Consultant @ Consultant (October 2019 - December 2022)
VP Program Management, Translational Biology, Founder @ Symic Bio (June 2012 - October 2019)
Consultant @ Consultant (August 2012 - September 2013)
Senior Research Scientist @ (November 2011 - August 2012)
Principal Scientist @ Glytrix (February 2009 - November 2011)
Postdoctoral Research and Teaching Fellow @ (February 2009 - May 2011)
Research Assistant @ Purdue University and Arizona State University (August 2004 - February 2009)
Kate Stuart Education
Purdue University
PhD (biomedical engineering)
2006-2009
Arizona State University
Biomedical Engineering (Biomedical Engineering)
2004-2006
Saint Louis University
B.S. (Biomedical Engineering)
2000-2004
Kate Stuart Skills
Pharmaceutics
IND
Budget Management
Program Development
Regulatory Submissions
Cross-functional Team Leadership
Program Management
Project Management
Cell Culture
ELISA
Western Blotting
Microscopy
Spectroscopy
Design of Experiments
Microsoft Office
Rheology
Design Expert
ImageJ
FPLC
Biomaterials
Glycosaminoglycans
Tissue Engineering
Grant Writing
Research
Publication Writing
Technical Presentations
Translational Research
Drug Development
Wound Healing
Biotechnology
Lifesciences
Biomedical Engineering
R&D
Animal Models
Kate Stuart Summary
Kate Stuart, based in San Francisco, CA, US, is currently a VP Program and Portfolio Management at Tenvie Therapeutics. Kate Stuart brings experience from previous roles at Tenvie Therapeutics, IHP Therapeutics, AN2 Therapeutics and Global Project Partners, LLC. Kate Stuart holds a 2006 - 2009 PhD in biomedical engineering @ Purdue University. With a robust skill set that includes Pharmaceutics, IND, Budget Management, Program Development, Regulatory Submissions and more. Kate Stuart has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Kate Stuart?
Find contact details for 700 million professionals.